Revenue: The sum of all revenue fields included for a company's operating activities.
Edwards Lifesciences Corporation (EW) had Revenue of $1.57B for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
$1.57B |
$91.20M |
|
$343.00M |
|
$1.23B |
|
$1.42B |
|
$151.10M |
|
$-60.70M |
|
$90.40M |
|
$190.20M |
|
$64.20M |
|
$64.20M |
|
$91.20M |
|
$181.46M |
|
$151.10M |
|
$193.80M |
|
584.80M |
|
585.80M |
|
$0.16 |
|
$0.16 |
|
| Balance Sheet Financials | |
$6.74B |
|
$1.81B |
|
$6.96B |
|
$13.70B |
|
$1.81B |
|
$598.30M |
|
$1.55B |
|
$3.36B |
|
$10.34B |
|
$7.44B |
|
$10.34B |
|
580.70M |
|
| Cash Flow Statement Financials | |
$1.60B |
|
$-712.90M |
|
$-956.80M |
|
$3.06B |
|
$2.94B |
|
$-119.30M |
|
$158.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.72 |
|
-- |
|
-- |
|
0.05 |
|
0.06 |
|
78.15% |
|
9.63% |
|
9.63% |
|
-- |
|
5.76% |
|
5.81% |
|
$1.33B |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.30 |
|
1.72 |
|
52.30 |
|
0.62% |
|
0.86% |
|
0.47% |
|
0.59% |
|
$17.80 |
|
$2.28 |
|
$2.72 |
|